The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Antioxidant stimulation as the adaptation mechanism in patients with metastatic urothelial cancers (MUC) treated with gemcitabine and cisplatin (GC).
Patrik Palacka
No relevant relationships to disclose
Jarmila Kucharska
No relevant relationships to disclose
Michal Mego
No relevant relationships to disclose
Jana Obertova
No relevant relationships to disclose
Jan Rajec
No relevant relationships to disclose
Daniela Svetlovska
No relevant relationships to disclose
Zuzana Sycova-Mila
No relevant relationships to disclose
Anna Mataseje
No relevant relationships to disclose
Jozef Mardiak
No relevant relationships to disclose
Anna Gvozdjakova
No relevant relationships to disclose